GlassScriptPhysician profile
David V Keller
NPI 1124192406
$3,406.92
in general payments reported to CMS, 2019-2025
27 companies · $1,050 in 2025
The $1,050 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $328 · 2023: $800 · 2024: $1,102 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,872 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,871.75 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $483.68 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $281.56 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $262.85 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $250.61 | 2021-2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $231.79 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Novo Nordisk INC | $210.58 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $205.26 | 2022-2025 | Farxiga, Wainua |
| Abbott Laboratories | $185.41 | 2022-2025 | Cardiomems |
| Merck Sharp & Dohme LLC | $173.98 | 2023-2025 | Verquvo, Winrevair |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $163.76 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.99 | 2022-2025 | Jardiance |
| Scpharmaceuticals INC. | $95.88 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $94.04 | 2022-2023 | |
| Cvrx, INC. | $89.25 | 2024-2025 | Barostim Neo System |
| Baxter Healthcare | $89.20 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $86.68 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $64.93 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $63.33 | 2024-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $59.26 | 2021-2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $57.11 | 2024-2025 | |
| Edwards Lifesciences Corporation | $31.88 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $31.28 | 2021-2023 | Repatha |
| Lundbeck LLC | $23.16 | 2021 | |
| Lilly USA, LLC | $19.56 | 2025 | Zepbound |
| Irhythm Technologies, INC. | $17.27 | 2024 | Zio Monitor, Zio Xt Patch |
| Altathera Pharmaceuticals LLC | $14.39 | 2025 | Sotalol Hydrochloride |
| Medtronic, INC. | $13.23 | 2024 | Mycarelink |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Keller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.